News | October 24, 2007

Speakers to Address Tumor Immunology, Biological Therapy

October 25, 2007 - The “Primer on Tumor Immunology and Biological Therapy” will be held on Thursday, Nov. 1, 2007 in Boston and feature several prominent speakers in the field of cancer research.

The educational program, developed by the International Society for Biological Therapy of Cancer, is organized by Martin A Cheever M.D. of the Fred Hutchinson Cancer Research Group and Kim A. Margolin, M.D. of the City of Hope Cancer Center. The primer’s presenters will provide a current overview of immunology and biological therapy regarding clinical applications for the treatment of cancer and address the current underpinnings of biological therapy and tumor immunology.

Participants include scientists working in industry, post-doctoral fellows, graduate students, practicing physicians and research technicians in the field of cancer research. Many attendees have substantial background in one specialized area of biological therapy or tumor immunology, but often have little or no familiarity with other areas. It is the goal of the Primer to help educate attendees in these other fields of study and practice.

This year’s audience will learn central concepts and recent advances in cancer vaccines, vaccine adjuvants, host-tumor interactions, the role of “danger” signals in integrating innate and adaptive immunity, T cell therapy, angiogenesis, antibody therapy and cytokines.

The complete listing of this year’s speakers includes:

Judah Folkman, M.D. – Children’s Hospital Boston
Patrick Hwu, MD – M.D. Anderson Cancer Center
Rakesh K. Jain, Ph.D. – Harvard Medical School
Kim A. Margolin, M.D. – City of Hope Cancer Center
Francesco Marincola, M.D. – National Institutes of Health
Polly Matzinger, Ph.D. – National Institutes of Allergy and Infectious Diseases
Ira H. Pastan, M.D. – National Institutes of Health
Kenneth Rock, M.D. – University of Massachusetts
Carmen Scheibenbogen, M.D. – Institut for Med Immunologie
Paul M. Sondel, MD, Ph.D. – University of Wisconsin
Louis M. Weiner, M.D. – Fox Chase Cancer Center

For more information:

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init